User login
VIDEO: Lessons from statin failure in COPD
SAN DIEGO – The failure of statins in the STATCOPE trial to prevent exacerbations of chronic obstructive pulmonary disease isn’t the only important message of the trial, Dr. Gerard J. Criner said in an interview after he presented the findings at an international conference of the American Thoracic Society.
Previous observational studies of statins in COPD that suggested survival benefits from the drugs probably didn’t screen out patients with indications for statin therapy, as STATCOPE (Statins in COPD Exacerbations) did, for a more pristine assessment, said Dr. Criner, professor of medicine and director of the medical intensive care unit and the ventilator rehabilitation unit at Temple University, Philadelphia. The real message may be that clinicians are missing patients who need statins but aren’t getting them, he suggested.
Dr. Criner also shared his take on other important statin trials presented at the meeting. Take a look.
The National Heart, Lung, and Blood Institute and the Canadian Institutes of Health Research funded the STATCOPE trial. The investigators reported financial associations with dozens of companies, including five of Dr. Criner’s coinvestigators who had financial associations with Merck, which makes a brand name formulation of simvastatin.
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
On Twitter @sherryboschert
SAN DIEGO – The failure of statins in the STATCOPE trial to prevent exacerbations of chronic obstructive pulmonary disease isn’t the only important message of the trial, Dr. Gerard J. Criner said in an interview after he presented the findings at an international conference of the American Thoracic Society.
Previous observational studies of statins in COPD that suggested survival benefits from the drugs probably didn’t screen out patients with indications for statin therapy, as STATCOPE (Statins in COPD Exacerbations) did, for a more pristine assessment, said Dr. Criner, professor of medicine and director of the medical intensive care unit and the ventilator rehabilitation unit at Temple University, Philadelphia. The real message may be that clinicians are missing patients who need statins but aren’t getting them, he suggested.
Dr. Criner also shared his take on other important statin trials presented at the meeting. Take a look.
The National Heart, Lung, and Blood Institute and the Canadian Institutes of Health Research funded the STATCOPE trial. The investigators reported financial associations with dozens of companies, including five of Dr. Criner’s coinvestigators who had financial associations with Merck, which makes a brand name formulation of simvastatin.
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
On Twitter @sherryboschert
SAN DIEGO – The failure of statins in the STATCOPE trial to prevent exacerbations of chronic obstructive pulmonary disease isn’t the only important message of the trial, Dr. Gerard J. Criner said in an interview after he presented the findings at an international conference of the American Thoracic Society.
Previous observational studies of statins in COPD that suggested survival benefits from the drugs probably didn’t screen out patients with indications for statin therapy, as STATCOPE (Statins in COPD Exacerbations) did, for a more pristine assessment, said Dr. Criner, professor of medicine and director of the medical intensive care unit and the ventilator rehabilitation unit at Temple University, Philadelphia. The real message may be that clinicians are missing patients who need statins but aren’t getting them, he suggested.
Dr. Criner also shared his take on other important statin trials presented at the meeting. Take a look.
The National Heart, Lung, and Blood Institute and the Canadian Institutes of Health Research funded the STATCOPE trial. The investigators reported financial associations with dozens of companies, including five of Dr. Criner’s coinvestigators who had financial associations with Merck, which makes a brand name formulation of simvastatin.
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
On Twitter @sherryboschert
AT THE ATS INTERNATIONAL CONFERENCE
VIDEO: PTSD common in survivors of critical illness
SAN DIEGO – Following an ICU stay, about one-fourth of critical illness survivors are affected by symptoms of posttraumatic stress disorder, a meta-analysis of studies representing 3,437 patients demonstrated.
During a press briefing at an international conference of the American Thoracic Society, Dr. Ann Parker, a fellow in pulmonary and critical care medicine at Johns Hopkins University, Baltimore, discussed the findings and noted that certain patient-related risk factors influenced the association, including younger age, preexisting mental health problems, and post-ICU memories of frightening experiences in the ICU.
On Twitter @dougbrunk
SAN DIEGO – Following an ICU stay, about one-fourth of critical illness survivors are affected by symptoms of posttraumatic stress disorder, a meta-analysis of studies representing 3,437 patients demonstrated.
During a press briefing at an international conference of the American Thoracic Society, Dr. Ann Parker, a fellow in pulmonary and critical care medicine at Johns Hopkins University, Baltimore, discussed the findings and noted that certain patient-related risk factors influenced the association, including younger age, preexisting mental health problems, and post-ICU memories of frightening experiences in the ICU.
On Twitter @dougbrunk
SAN DIEGO – Following an ICU stay, about one-fourth of critical illness survivors are affected by symptoms of posttraumatic stress disorder, a meta-analysis of studies representing 3,437 patients demonstrated.
During a press briefing at an international conference of the American Thoracic Society, Dr. Ann Parker, a fellow in pulmonary and critical care medicine at Johns Hopkins University, Baltimore, discussed the findings and noted that certain patient-related risk factors influenced the association, including younger age, preexisting mental health problems, and post-ICU memories of frightening experiences in the ICU.
On Twitter @dougbrunk
AT ATS 2014
The Changing Landscape of VTE Treatment
For more presentations from the 9th Annual Meeting of the Association of VA Hematology/Oncology (AVAHO), click here: AVAHO Meeting Presentations
For more presentations from the 9th Annual Meeting of the Association of VA Hematology/Oncology (AVAHO), click here: AVAHO Meeting Presentations
For more presentations from the 9th Annual Meeting of the Association of VA Hematology/Oncology (AVAHO), click here: AVAHO Meeting Presentations
Partially enclosed morcellation of a uterus during LSH using laparoscopic morcellation bag
Dr. Kondrup is Assistant Clinical Professor, Department of Obstetrics and Gynecology, Upstate Medical Center Syracuse, Binghamton, New York, and is in private practice at Lourdes Hospital, Broome OB/GYN, Binghamton.
Dr. Kondrup reports that he is a trainer, speaker, and consultant to Ethicon EndoSurgery and Ethicon Surgical Care; a member of the speakers' bureau for Myriad Genetics; and a consultant to PALL Medical.
Dr. Kondrup is Assistant Clinical Professor, Department of Obstetrics and Gynecology, Upstate Medical Center Syracuse, Binghamton, New York, and is in private practice at Lourdes Hospital, Broome OB/GYN, Binghamton.
Dr. Kondrup reports that he is a trainer, speaker, and consultant to Ethicon EndoSurgery and Ethicon Surgical Care; a member of the speakers' bureau for Myriad Genetics; and a consultant to PALL Medical.
Dr. Kondrup is Assistant Clinical Professor, Department of Obstetrics and Gynecology, Upstate Medical Center Syracuse, Binghamton, New York, and is in private practice at Lourdes Hospital, Broome OB/GYN, Binghamton.
Dr. Kondrup reports that he is a trainer, speaker, and consultant to Ethicon EndoSurgery and Ethicon Surgical Care; a member of the speakers' bureau for Myriad Genetics; and a consultant to PALL Medical.
VIDEO – Personalized medicine for schizophrenia is a reality
NEW YORK – Selecting patients according to genotype and repurposing existing drugs for use in combination with drugs that enhance psychosocial interventions are among the new therapeutic opportunities in treating schizophrenia, Dr. Donald C. Goff said in an interview during the annual meeting of the American Psychiatric Association.
In this video, Dr. Goff of the Nathan Kline Institute for Psychiatric Research at New York University also discusses how combining drugs with psychosocial interventions can lead to areas of growth.
NEW YORK – Selecting patients according to genotype and repurposing existing drugs for use in combination with drugs that enhance psychosocial interventions are among the new therapeutic opportunities in treating schizophrenia, Dr. Donald C. Goff said in an interview during the annual meeting of the American Psychiatric Association.
In this video, Dr. Goff of the Nathan Kline Institute for Psychiatric Research at New York University also discusses how combining drugs with psychosocial interventions can lead to areas of growth.
NEW YORK – Selecting patients according to genotype and repurposing existing drugs for use in combination with drugs that enhance psychosocial interventions are among the new therapeutic opportunities in treating schizophrenia, Dr. Donald C. Goff said in an interview during the annual meeting of the American Psychiatric Association.
In this video, Dr. Goff of the Nathan Kline Institute for Psychiatric Research at New York University also discusses how combining drugs with psychosocial interventions can lead to areas of growth.
FROM THE APA ANNUAL MEETING
EXCLUSIVE VIDEO: MERS – What physicians need to know
VANCOUVER, B.C. – Dr. Daniel C. Payne has been investigating the Middle East Respiratory Syndrome coronavirus since the first case was reported in the Arabian Peninsula nearly 2 years ago.
An epidemiologist with the Centers for Disease Control and Prevention, Dr. Payne has traveled to the sites of outbreak and has worked with foreign officials to study and track down the virus.
Meanwhile, in the United States, CDC officials have been preparing for the potential arrival of the virus for the past year, Dr. Payne said. So when the first case was confirmed on May 2 in Munster, Ind., all the pieces were in place and health officials were ready.
How big a worry is MERS for U.S. physicians, what critical questions should they ask their patients, and what precautions should they take? Dr. Payne addressed some of these major concerns in a video interview during the annual meeting of the Pediatric Academic Societies and shared the silver lining to the virus’s arrival in the United States.
He also encouraged physicians to check the CDC website for the latest updates and practice protocols. Physicians can also visit the World Health Organization’s website for the latest global updates.
On Twitter @naseemmiller
VANCOUVER, B.C. – Dr. Daniel C. Payne has been investigating the Middle East Respiratory Syndrome coronavirus since the first case was reported in the Arabian Peninsula nearly 2 years ago.
An epidemiologist with the Centers for Disease Control and Prevention, Dr. Payne has traveled to the sites of outbreak and has worked with foreign officials to study and track down the virus.
Meanwhile, in the United States, CDC officials have been preparing for the potential arrival of the virus for the past year, Dr. Payne said. So when the first case was confirmed on May 2 in Munster, Ind., all the pieces were in place and health officials were ready.
How big a worry is MERS for U.S. physicians, what critical questions should they ask their patients, and what precautions should they take? Dr. Payne addressed some of these major concerns in a video interview during the annual meeting of the Pediatric Academic Societies and shared the silver lining to the virus’s arrival in the United States.
He also encouraged physicians to check the CDC website for the latest updates and practice protocols. Physicians can also visit the World Health Organization’s website for the latest global updates.
On Twitter @naseemmiller
VANCOUVER, B.C. – Dr. Daniel C. Payne has been investigating the Middle East Respiratory Syndrome coronavirus since the first case was reported in the Arabian Peninsula nearly 2 years ago.
An epidemiologist with the Centers for Disease Control and Prevention, Dr. Payne has traveled to the sites of outbreak and has worked with foreign officials to study and track down the virus.
Meanwhile, in the United States, CDC officials have been preparing for the potential arrival of the virus for the past year, Dr. Payne said. So when the first case was confirmed on May 2 in Munster, Ind., all the pieces were in place and health officials were ready.
How big a worry is MERS for U.S. physicians, what critical questions should they ask their patients, and what precautions should they take? Dr. Payne addressed some of these major concerns in a video interview during the annual meeting of the Pediatric Academic Societies and shared the silver lining to the virus’s arrival in the United States.
He also encouraged physicians to check the CDC website for the latest updates and practice protocols. Physicians can also visit the World Health Organization’s website for the latest global updates.
On Twitter @naseemmiller
AT THE PAS ANNUAL MEETING
VIDEO: Creative cuts make more aesthetic surgical dressings
ORLANDO – A few cuts in the surgical dressing material, a process that Dr. Kristin Smallwood calls ‘pinking,’ can make a big difference for patients.
Dr. Smallwood was inspired by the cutting techniques used in sewing and quickly realized that a few cuts here and there on the wound dressing not only helped with applying appropriate pressure, but also yielded more aesthetically pleasing results.
In an interview at the annual meeting of the Florida Society of Dermatology and Dermatologic Surgery, Dr. Smallwood, who practices in Cocoa Beach, Fla., shows exactly how she makes her creative cuts.
On Twitter @naseemsmiller
ORLANDO – A few cuts in the surgical dressing material, a process that Dr. Kristin Smallwood calls ‘pinking,’ can make a big difference for patients.
Dr. Smallwood was inspired by the cutting techniques used in sewing and quickly realized that a few cuts here and there on the wound dressing not only helped with applying appropriate pressure, but also yielded more aesthetically pleasing results.
In an interview at the annual meeting of the Florida Society of Dermatology and Dermatologic Surgery, Dr. Smallwood, who practices in Cocoa Beach, Fla., shows exactly how she makes her creative cuts.
On Twitter @naseemsmiller
ORLANDO – A few cuts in the surgical dressing material, a process that Dr. Kristin Smallwood calls ‘pinking,’ can make a big difference for patients.
Dr. Smallwood was inspired by the cutting techniques used in sewing and quickly realized that a few cuts here and there on the wound dressing not only helped with applying appropriate pressure, but also yielded more aesthetically pleasing results.
In an interview at the annual meeting of the Florida Society of Dermatology and Dermatologic Surgery, Dr. Smallwood, who practices in Cocoa Beach, Fla., shows exactly how she makes her creative cuts.
On Twitter @naseemsmiller
AT FSDDS 14
VIDEO: Best practices in treating low testosterone in men
LAS VEGAS – Analysis of data from a company that provides therapy for low testosterone showed that the treatment was not associated with a higher risk of myocardial infarction and stroke in men, and it may have played a protective role.
The findings clash with what two recent studies – one published in JAMA and the other in PLoS One – found, which showed that testosterone therapy increased the risk of MI and stroke in men, prompting the Food and Drug Administration to reassess the safety of the approved treatments.
Dr. Aaron Vinik, Murray Waitzer Endowed Chair for Diabetes Research at Eastern Virginia Medical School, Norfolk, puts the studies in perspective in this interview, and shares how patients should be treated based on current data and available knowledge.
nmiller@frontlinemedcom.com On Twitter @naseemsmiller
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
LAS VEGAS – Analysis of data from a company that provides therapy for low testosterone showed that the treatment was not associated with a higher risk of myocardial infarction and stroke in men, and it may have played a protective role.
The findings clash with what two recent studies – one published in JAMA and the other in PLoS One – found, which showed that testosterone therapy increased the risk of MI and stroke in men, prompting the Food and Drug Administration to reassess the safety of the approved treatments.
Dr. Aaron Vinik, Murray Waitzer Endowed Chair for Diabetes Research at Eastern Virginia Medical School, Norfolk, puts the studies in perspective in this interview, and shares how patients should be treated based on current data and available knowledge.
nmiller@frontlinemedcom.com On Twitter @naseemsmiller
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
LAS VEGAS – Analysis of data from a company that provides therapy for low testosterone showed that the treatment was not associated with a higher risk of myocardial infarction and stroke in men, and it may have played a protective role.
The findings clash with what two recent studies – one published in JAMA and the other in PLoS One – found, which showed that testosterone therapy increased the risk of MI and stroke in men, prompting the Food and Drug Administration to reassess the safety of the approved treatments.
Dr. Aaron Vinik, Murray Waitzer Endowed Chair for Diabetes Research at Eastern Virginia Medical School, Norfolk, puts the studies in perspective in this interview, and shares how patients should be treated based on current data and available knowledge.
nmiller@frontlinemedcom.com On Twitter @naseemsmiller
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
EXPERT ANALYSIS FROM AACE 2014
VIDEO: U.S. Hispanics show varying diabetes rates by country of origin
LAS VEGAS – When it comes to treating Hispanic patients, one size doesn’t fit all, according to results from the ongoing Hispanic Community Health Study/Study of Latinos.
In a video interview, Dr. Larissa Avilés-Santa, a medical officer at the National Heart, Lung, and Blood Institute in Bethesda, Md., talks about the study’s findings and provides advice to physicians at the annual meeting of the American Association of Clinical Endocrinologists.
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
On Twitter @naseemmiller
LAS VEGAS – When it comes to treating Hispanic patients, one size doesn’t fit all, according to results from the ongoing Hispanic Community Health Study/Study of Latinos.
In a video interview, Dr. Larissa Avilés-Santa, a medical officer at the National Heart, Lung, and Blood Institute in Bethesda, Md., talks about the study’s findings and provides advice to physicians at the annual meeting of the American Association of Clinical Endocrinologists.
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
On Twitter @naseemmiller
LAS VEGAS – When it comes to treating Hispanic patients, one size doesn’t fit all, according to results from the ongoing Hispanic Community Health Study/Study of Latinos.
In a video interview, Dr. Larissa Avilés-Santa, a medical officer at the National Heart, Lung, and Blood Institute in Bethesda, Md., talks about the study’s findings and provides advice to physicians at the annual meeting of the American Association of Clinical Endocrinologists.
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
On Twitter @naseemmiller
AT AACE 14
VIDEO: HbA1c focus of diabetes education program
LAS VEGAS – In its fourth year, the Blood Sugar Basics program, which is the American College of Endocrinology and Merck’s diabetes education program, is turning its attention to hemoglobin A1c, because many patients with diabetes fail to achieve an HbA1c of 6.5% or less, the program’s leaders said.
This year’s campaign was unveiled at the annual meeting of the American Association of Clinical Endocrinologists.
With the goal of increasing the number of patients who achieve their HbA1c goal, the program has established three missions for patients: Talk to your physician; set goals and commit to a plan; and revisit and reassess.
The program’s website (bloodsugarbasics.com), which has had a facelift, provides forms and easy-to-follow guidelines for patients. The association is also distributing printed information about the program to AACE members, and this year, it is reaching out to primary care physicians, because there simply aren’t enough endocrinologists, said Dr. Etie Moghissi, who has helped develop the program since its inception in 2010.
Blood Sugar Basics is among a handful of credible diabetes education programs online, including the National Diabetes Education Program.
In a video interview, Dr. Moghissi of the department of medicine at the University of California, Los Angeles, explains the program’s goals, and why physicians should consider it as an educational source for their patients.
On Twitter @naseemsmiller
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
LAS VEGAS – In its fourth year, the Blood Sugar Basics program, which is the American College of Endocrinology and Merck’s diabetes education program, is turning its attention to hemoglobin A1c, because many patients with diabetes fail to achieve an HbA1c of 6.5% or less, the program’s leaders said.
This year’s campaign was unveiled at the annual meeting of the American Association of Clinical Endocrinologists.
With the goal of increasing the number of patients who achieve their HbA1c goal, the program has established three missions for patients: Talk to your physician; set goals and commit to a plan; and revisit and reassess.
The program’s website (bloodsugarbasics.com), which has had a facelift, provides forms and easy-to-follow guidelines for patients. The association is also distributing printed information about the program to AACE members, and this year, it is reaching out to primary care physicians, because there simply aren’t enough endocrinologists, said Dr. Etie Moghissi, who has helped develop the program since its inception in 2010.
Blood Sugar Basics is among a handful of credible diabetes education programs online, including the National Diabetes Education Program.
In a video interview, Dr. Moghissi of the department of medicine at the University of California, Los Angeles, explains the program’s goals, and why physicians should consider it as an educational source for their patients.
On Twitter @naseemsmiller
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
LAS VEGAS – In its fourth year, the Blood Sugar Basics program, which is the American College of Endocrinology and Merck’s diabetes education program, is turning its attention to hemoglobin A1c, because many patients with diabetes fail to achieve an HbA1c of 6.5% or less, the program’s leaders said.
This year’s campaign was unveiled at the annual meeting of the American Association of Clinical Endocrinologists.
With the goal of increasing the number of patients who achieve their HbA1c goal, the program has established three missions for patients: Talk to your physician; set goals and commit to a plan; and revisit and reassess.
The program’s website (bloodsugarbasics.com), which has had a facelift, provides forms and easy-to-follow guidelines for patients. The association is also distributing printed information about the program to AACE members, and this year, it is reaching out to primary care physicians, because there simply aren’t enough endocrinologists, said Dr. Etie Moghissi, who has helped develop the program since its inception in 2010.
Blood Sugar Basics is among a handful of credible diabetes education programs online, including the National Diabetes Education Program.
In a video interview, Dr. Moghissi of the department of medicine at the University of California, Los Angeles, explains the program’s goals, and why physicians should consider it as an educational source for their patients.
On Twitter @naseemsmiller
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
AT AACE 2014
